GHRP-2 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of GHRP-2 is approximately 30 minutes; peak GH response ~15 minutes post-injection. This means dosing 2-3 times daily on empty stomach is typical to maintain stable levels. The half-life directly affects how long GHRP-2 remains active and influences optimal injection timing.
What Is the Half-Life of GHRP-2?
The half-life of GHRP-2 is approximately 30 minutes; peak GH response ~15 minutes post-injection. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer GHRP-2 to maintain therapeutic blood levels.
What Does GHRP-2's Half-Life Mean for Dosing?
With a half-life of approximately 30 minutes; peak GH response ~15 minutes post-injection, GHRP-2 requires dosing 2-3 times daily on empty stomach to maintain stable levels. The standard dosage of 100-300 mcg per injection via subcutaneous injection, intranasal spray accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, GHRP-2 reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For GHRP-2, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject GHRP-2?
Optimal timing depends on your research goals. A half-life of approximately 30 minutes; peak GH response ~15 minutes post-injection means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (2-3 times daily on empty stomach) for more stable levels throughout the day.
How Does GHRP-2's Half-Life Compare to Similar Peptides?
GHRP-2 is a Growth hormone secretagogue, ghrelin receptor agonist. Its half-life of approximately 30 minutes; peak GH response ~15 minutes post-injection positions it with a shorter duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your GHRP-2 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for GHRP-2.
Open Calculator →Bottom Line: GHRP-2 Half-Life and Dosing
GHRP-2 has a half-life of approximately 30 minutes; peak GH response ~15 minutes post-injection, supporting the standard protocol of 100-300 mcg per injection dosed 2-3 times daily on empty stomach over 8-16 weeks with cycling protocols recommended.
Read our GHRP-2 dosage guide for complete protocol details.
Complete Guide
GHRP-2: Growth Hormone Releasing Peptide 2
Related Reading
- GHRP-2 Dosage Guide
- GHRP-2 Benefits
- GHRP-2 Side Effects
- GHRP-2 Stacking Guide
- GHRP-2 Cycle Guide
- GHRP-2 Research
Research-Grade Sourcing
If you're going to research GHRP-2, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is GHRP-2?
GHRP-2 (Growth Hormone Releasing Peptide-2) is a Growth hormone secretagogue, ghrelin receptor agonist. Synthetic hexapeptide designed to stimulate GH release by mimicking ghrelin at the GHS-R receptor. It is researched for potent GH elevation, lean muscle mass gain, improved recovery, IGF-1 increases, increased appetite, bone density support.
What is the recommended GHRP-2 dosage?
Common dosages: 100-300 mcg per injection administered 2-3 times daily on empty stomach via subcutaneous injection, intranasal spray. Cycle length: 8-16 weeks with cycling protocols recommended. Half-life: approximately 30 minutes; peak GH response ~15 minutes post-injection. Use our peptide calculator for exact reconstitution math.
What are the side effects of GHRP-2?
Significant appetite increase within 20 minutes of injection. Elevated cortisol and prolactin in dose-dependent manner. Water retention, potential sleep quality reduction at high doses, injection site reactions. Possible insulin desensitization with chronic use.
Is GHRP-2 safe?
GHRP-2 has shown a preliminary safety profile in research. Not FDA-approved. WADA prohibited at all times. Available as research chemical. All research should follow appropriate safety protocols.